Ariad Pharma (ARIA) Posts Wider than Expected Q2 Loss of 31c/Share

Ariad Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• BofA says momentum style supported by earnings revisions
• Piper Sandler Reiterates Overweight Rating on Patterson-UTI Energy (PTEN)